Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
Medicina,
Год журнала:
2025,
Номер
61(1), С. 67 - 67
Опубликована: Янв. 3, 2025
Background
and
Objectives:
Three
respiratory
syncytial
virus
(RSV)
vaccines
have
been
recently
made
available
for
older
adults.
Understanding
the
principal
characteristics
of
first
vaccine-takers
can
pave
way
a
successful
vaccination
campaign.
The
objective
this
study
was
to
explore
sociodemographic
clinical
Italian
users
an
adjuvanted
RSV
vaccine
their
attitudes
towards
vaccination.
Materials
Methods:
This
cross-sectional
conducted
in
2024
Liguria
(Italy).
Individuals
aged
≥60
years
with
no
contraindications
RSVPreF3
OA
were
eligible.
Following
vaccination,
subjects
filled
questionnaire,
which
comprised
items
on
characteristics,
trust
indicator
(VTI).
Results:
A
total
453
vaccinees
completed
survey.
Their
mean
age
74.9
±
8.0
years,
50.6%
males.
Nine
ten
(89.2%)
individuals
had
≥1
co-morbidity,
cardiovascular
conditions
(70.4%),
diseases
(27.6%)
diabetes
(18.5%)
most
common.
Uptake
routine
high:
91.2%
98.7%
received
2023/2024
season
influenza
≥2
COVID-19
vaccines,
respectively.
common
reasons
current
general
practitioner
advice
(43.9%),
followed
by
willingness
be
protected
against
(20.8%)
feelings
being
at
risk
(16.6%)
RSV.
average
VTI
score
91.5%,
suggesting
high
vaccines.
More
positive
observed
(p
<
0.01)
among
who
more
doses,
whose
or
good
health
feeling
Conclusions:
novel
represented
high-risk
comparatively
prevalence
co-morbidities,
uptake
seasonal
immunization.
Язык: Английский
Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review
Vaccines,
Год журнала:
2025,
Номер
13(2), С. 159 - 159
Опубликована: Фев. 6, 2025
Background:
New
strategies
for
respiratory
syncytial
virus
(RSV)
prevention
are
available
and
in
development,
but
their
acceptance
is
crucial
to
effectiveness.
Objectives:
This
systematic
review
aims
summarize
current
quantitative
qualitative
evidence
regarding
knowledge
attitudes
relating
RSV
prevention.
Methods:
Six
databases
(PubMed,
Scopus,
APA
PsycArticles;
PsycInfo;
CINAHL
Complete;
Psychology
Behavioral
Sciences
Collection)
two
preprint
repositories
(medRxiv
Preprints)
were
searched
up
until
23
December
2024
(PROSPERO:
CRD42024602351).
Results:
Sixty-one
articles
included,
focusing
on
vaccination
the
elderly
adults
at
risk
(n
=
10)
or
pregnant
people
24,
of
which
8
also
examined
preferences
maternal
vs.
infant
immunization)
immunization
27,
16
focused
palivizumab,
with
6
adherence
its
monthly
administration).
Eighteen
assessed
healthcare
professionals.
Overall,
findings
showed
limited
awareness
generally
positive
towards
moderate
high
intentions
uptake
rates.
Protection
against
disease
perceived
severity
promoted
acceptance,
whereas
concerns
about
side
effects
hindered
it.
Maternal
was
more
acceptable
than
immunization.
Conclusions:
Attitudes
options
favorable.
Should
become
available,
may
depend
characteristics,
how
they
framed
presented.
These
insights
highlight
importance
education
grounded
decision-making
literature,
while
recognizing
likely
favorable
reception
preventive
measures
across
target
age-populations.
Язык: Английский
Factors influencing acceptance of RSV immunization for newborns among pregnant individuals: A mixed-methods study
Vaccine,
Год журнала:
2025,
Номер
55, С. 127062 - 127062
Опубликована: Март 31, 2025
Respiratory
syncytial
virus
(RSV)
is
a
major
cause
of
respiratory
infections
and
hospitalizations
in
Canadian
infants.
Recently,
Health
Canada
approved
two
novel
immunizing
products:
vaccine
given
during
pregnancy
monoclonal
antibody
for
This
study
assessed
knowledge,
attitudes,
intentions
regarding
RSV
its
prevention
among
pregnant
individuals.
A
mixed-methods
was
conducted
Quebec
from
October
to
December
2023.
Pregnant
individuals
were
recruited
through
targeted
Facebook
advertisements.
Data
collected
phases:
Phase
1
involved
an
online
survey
assess
knowledge
RSV,
attitudes
toward
immunization,
both
immunization
products,
followed
by
qualitative
interviews
2
explore
factors
impacting
decision-making
preferences
prevention.
Survey
data
analyzed
using
descriptive
statistics;
interview
thematic
analysis.
Among
participants
(n
=
803),
68.4
%
reported
some
RSV.
Intention
products
high,
with
88.1
willing
receive
the
92
%,
administer
antibodies
their
majority
(69
%)
preferred
vaccination
over
antibodies.
The
desire
protect
infant
severe
complications
key
motivating
factor
acceptance
new
products.
Other
determinants
included
safety,
efficacy,
recommendations
healthcare
providers.
Qualitative
25)
highlighted
safety
concerns
expectant
parents
about
these
importance
clear
evidence-based
providers
also
emphasized.
demonstrated
high
level
interest
infants,
whether
or
Recommendations
availability
information
on
efficacy
will
be
move
intention
action.
Язык: Английский